|Alterola Biotech Inc -- USA Stock|| |
USD 1.55 0.00 0.00%
President Co-Manager, Member of the Executive Committee
Mr. Alain Taravella was the President, CoManager and Member of the Executive Committee of Altarea SCA since June 26, 2007 and is also a Member of the Company Operation Committee and Strategy Committee. Prior to that, he had been Chief Executive Officer and Chairman of the Board of Altarea since September 2, 2004 and was also a Member of the Investment Committee. Between 1975 and 1994, he held several roles in Pierre et Vacances, where he was named Managing Director in 1985. In 1994 he created the Altarea group, which he has managed ever since. He is a graduate of Hautes Etudes Commerciales
Age: 67 President Since 2007
Taravella also holds other mandates, including CoManager of Altareit, President of Altafinance 2, Alta Patrimoine and Altafi 2, Chairman of the American, Spanish and Italian subsidiaries of Altarea, Chairman and Chief Executive Officer of Aldeta and Chairman of the Supervisory Board of Cogedim and Altarea France.
The company has return on total asset (ROA)
of (133.34) %
which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech Inc has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech is traded on OTC Market in USA.Alterola Biotech Inc (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.